CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Total Assets (Quarterly): 434.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 434.69M |
| September 30, 2023 | 451.05M |
| June 30, 2023 | 226.65M |
| March 31, 2023 | 245.32M |
| December 31, 2022 | 141.85M |
| September 30, 2022 | 159.25M |
| June 30, 2022 | 177.72M |
| March 31, 2022 | 200.64M |
| December 31, 2021 | 202.32M |
| September 30, 2021 | 122.90M |
| June 30, 2021 | 117.04M |
| March 31, 2021 | 136.68M |
| December 31, 2020 | 153.82M |
| September 30, 2020 | 168.49M |
| June 30, 2020 | 176.60M |
| March 31, 2020 | 188.60M |
| December 31, 2019 | 205.73M |
| September 30, 2019 | 231.80M |
| June 30, 2019 | 253.44M |
| March 31, 2019 | 274.16M |
| December 31, 2018 | 186.75M |
| Date | Value |
|---|---|
| September 30, 2018 | 203.71M |
| June 30, 2018 | 218.17M |
| March 31, 2018 | 232.26M |
| December 31, 2017 | 104.25M |
| September 30, 2017 | 104.34M |
| June 30, 2017 | 18.73M |
| March 31, 2017 | 25.38M |
| December 31, 2016 | 19.36M |
| September 30, 2016 | 24.79M |
| June 30, 2016 | 30.48M |
| March 31, 2016 | 36.77M |
| December 31, 2015 | 43.08M |
| September 30, 2015 | 48.86M |
| June 30, 2015 | 28.67M |
| March 31, 2015 | 34.73M |
| December 31, 2014 | 37.47M |
| September 30, 2014 | 44.65M |
| June 30, 2014 | 26.03M |
| March 31, 2014 | 31.20M |
| December 31, 2013 | 32.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
117.04M
Minimum
Jun 2021
451.05M
Maximum
Sep 2023
210.24M
Average
188.60M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 56.29B |
| Assure Holdings Corp | 7.514M |
| Societal CDMO Inc (DELISTED) | 153.47M |
| AN2 Therapeutics Inc | 138.74M |
| Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 142.43M |
| Shareholders Equity (Quarterly) | 292.26M |
| Debt to Equity Ratio | 0.3735 |
| Current Ratio | 10.96 |
| Net Debt Paydown Yield | -0.17% |